Impact of transplanted CD 34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation.

被引：0
|
作者：
Sohn, SK [1 ]
Kim, DH [1 ]
Kim, JG [1 ]
Suh, JS [1 ]
Lee, KB [1 ]
机构：
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5387
引用
收藏
页码：453B / 453B
页数：1
相关论文
共 50 条
  • [21] Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation.
    Frère, P
    Pereira, M
    Fillet, G
    Beguin, Y
    BLOOD, 2004, 104 (11) : 354B - 354B
  • [22] Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide
    Hany Elmariah
    Syeda Mahrukh Hussnain Naqvi
    Jongphil Kim
    Taiga Nishihori
    Asmita Mishra
    Lia Perez
    Rawan Faramand
    Aleksandr Lazaryan
    Hien D. Liu
    Farhad Khimani
    Michael Nieder
    Claudio Anasetti
    Joseph Pidala
    Nelli Bejanyan
    Bone Marrow Transplantation, 2021, 56 : 1683 - 1690
  • [23] Impact of CD34+ cell dose on the outcome of 65 patients undergoing reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. Experience in a single institution in Spain
    Martinez-Barranco, P
    Gayoso, J
    Fores, R
    Bautista, G
    Ruiz, E
    Navarro, B
    Marco, JG
    Gil, S
    Regidor, C
    Sanjuan, I
    Cabrera, R
    BONE MARROW TRANSPLANTATION, 2005, 35 : S206 - S207
  • [24] Impact of transplant CD34+cell dose on outcomes after allogeneic peripheral blood stem cell transplantation from a matched unrelated donor.
    Nakamura, R
    Smith, D
    Parker, P
    Senitzer, D
    Rodriguez, R
    Falk, P
    Fung, H
    Kirschbaum, M
    Kogut, N
    Krishnan, A
    O'Donnell, MR
    Popplewell, L
    Pullarkat, V
    Sahebi, F
    Smith, E
    Snyder, D
    Spielberger, R
    Stein, A
    Zain, J
    Forman, SJ
    Nademanee, A
    BLOOD, 2003, 102 (11) : 488A - 488A
  • [25] Impact of CD34+stem cell dose on early mortality after allogeneic hematopoietic stem cell transplantation
    Neumann, K.
    Lange, S.
    Kragl, B.
    Glass, A.
    Grosse-Thie, C.
    Wittke, C.
    Freitag, S.
    Henze, L.
    Kleine, H. -D.
    Junghanss, C.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S567 - S567
  • [26] Infections after autologous CD34 selected peripheral blood stem cell transplantation.
    Crippa, F
    Holmberg, L
    Hooper, H
    Carter, R
    Marr, K
    Bensinger, W
    Chauncey, T
    Corey, L
    Boeckh, M
    BLOOD, 2000, 96 (11) : 586A - +
  • [27] Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiation
    Singh, Anurag K.
    Savani, Bipin N.
    Albert, Paul S.
    Barrett, A. John
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (03) : 339 - 344
  • [28] Evaluation of a high CD34(+) cell dose for hematopoietic stem cell transplantation.
    Rybka, WB
    Kiss, J
    Lister, J
    deMagalhaesSilverman, M
    Ball, ED
    BLOOD, 1996, 88 (10) : 1596 - 1596
  • [29] CD34+cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
    Díez-Campelo, M
    Pérez-Simón, JA
    Ocio, EM
    Castilla, C
    González-Porras, JR
    Sánchez-Guijo, FM
    Vázquez, L
    Caballero, MD
    Cañizo, MC
    San Miguel, JF
    LEUKEMIA & LYMPHOMA, 2005, 46 (02) : 177 - 183
  • [30] CD34+Cell Dose Influences Survival after Allogeneic Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Elmariah, Hany
    Naqvi, Syeda Mahrukh Hussnain
    Kim, Jongphil
    Nishihori, Taiga
    Mishra, Asmita
    Perez, Lia
    Liu, Hien D.
    Khimani, Farhad
    Nieder, Michael
    Pidala, Joseph
    Bejanyan, Nelli
    BLOOD, 2019, 134
12345